Don't get left behind! The modernized is coming. Check it out now.
Say goodbye to!
The new site is coming soon - go to the modernized
Working… Menu

Safety Study to Assess AFM11 in Patients With Relapsed and/or Refractory CD19 Positive B-cell NHL

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02106091
Recruitment Status : Terminated (Non-favorable risk/benefit profile with studied dosing regimen)
First Posted : April 8, 2014
Last Update Posted : June 18, 2019
Information provided by (Responsible Party):
Affimed GmbH

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : August 2018
Actual Study Completion Date : September 2018